These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1464 related items for PubMed ID: 12447876
21. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells. Secchiero P, Milani D, Gonelli A, Melloni E, Campioni D, Gibellini D, Capitani S, Zauli G. J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939 [Abstract] [Full Text] [Related]
22. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
23. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K, Douglas L, Delaney AB, Houghton JA. Cancer Res; 2004 Nov 01; 64(21):8036-44. PubMed ID: 15520213 [Abstract] [Full Text] [Related]
24. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential. Hotta T, Suzuki H, Nagai S, Yamamoto K, Imakiire A, Takada E, Itoh M, Mizuguchi J. J Orthop Res; 2003 Sep 01; 21(5):949-57. PubMed ID: 12919886 [Abstract] [Full Text] [Related]
25. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death. Thomas RP, Farrow BJ, Kim S, May MJ, Hellmich MR, Evers BM. Surgery; 2002 Aug 01; 132(2):127-34. PubMed ID: 12219002 [Abstract] [Full Text] [Related]
26. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2. Diessenbacher P, Hupe M, Sprick MR, Kerstan A, Geserick P, Haas TL, Wachter T, Neumann M, Walczak H, Silke J, Leverkus M. J Invest Dermatol; 2008 May 01; 128(5):1134-47. PubMed ID: 17989734 [Abstract] [Full Text] [Related]
27. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP, Zisman A, Bonavida B. Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140 [Abstract] [Full Text] [Related]
28. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH. Int J Cancer; 2001 Jul 15; 93(2):262-8. PubMed ID: 11410875 [Abstract] [Full Text] [Related]
29. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Ito M, Takase K, Moriyama M, Nakano T, Suzuki A. Hepatology; 2000 Sep 15; 32(3):482-90. PubMed ID: 10960439 [Abstract] [Full Text] [Related]
30. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. Immunity; 2000 Jun 15; 12(6):611-20. PubMed ID: 10894161 [Abstract] [Full Text] [Related]
31. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R, Bedi A. Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014 [Abstract] [Full Text] [Related]
32. Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. Varfolomeev E, Maecker H, Sharp D, Lawrence D, Renz M, Vucic D, Ashkenazi A. J Biol Chem; 2005 Dec 09; 280(49):40599-608. PubMed ID: 16227629 [Abstract] [Full Text] [Related]
33. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines. Guseva NV, Taghiyev AF, Sturm MT, Rokhlin OW, Cohen MB. Mol Cancer Res; 2004 Oct 09; 2(10):574-84. PubMed ID: 15498932 [Abstract] [Full Text] [Related]
34. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Lin Y, Devin A, Cook A, Keane MM, Kelliher M, Lipkowitz S, Liu ZG. Mol Cell Biol; 2000 Sep 09; 20(18):6638-45. PubMed ID: 10958661 [Abstract] [Full Text] [Related]
35. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis. Kim JH, Ajaz M, Lokshin A, Lee YJ. Clin Cancer Res; 2003 Aug 01; 9(8):3134-41. PubMed ID: 12912965 [Abstract] [Full Text] [Related]
36. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells. Petak I, Vernes R, Szucs KS, Anozie M, Izeradjene K, Douglas L, Tillman DM, Phillips DC, Houghton JA. Cell Death Differ; 2003 Jun 01; 10(6):729-39. PubMed ID: 12761581 [Abstract] [Full Text] [Related]
37. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J. Nat Immunol; 2000 Dec 01; 1(6):489-95. PubMed ID: 11101870 [Abstract] [Full Text] [Related]
38. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC. Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS. Oncogene; 2004 Aug 12; 23(36):6083-94. PubMed ID: 15208670 [Abstract] [Full Text] [Related]
39. Protein Kinase-Mediated Decision Between the Life and Death. Engin A. Adv Exp Med Biol; 2021 Aug 12; 1275():1-33. PubMed ID: 33539010 [Abstract] [Full Text] [Related]
40. The TRAIL DISCussion: It is FADD and caspase-8! Peter ME. Cell Death Differ; 2000 Sep 12; 7(9):759-60. PubMed ID: 11042670 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]